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Abstract
Background: Chronic inflammation from recurring trauma is an underlying pathophysiological basis of numerous diseases.
Furthermore, it may result in cell death, scarring, fibrosis, and loss of tissue function. In states of inflammation, subsequent
increases in oxidative stress and cellular division may lead to the accelerated erosion of telomeres, crucial genomic
structures which protect chromosomes from decay. However, the association between plasma inflammatory marker
concentrations and telomere length has been inconsistent in previous studies.
Objective: The purpose of this study was to determine the longitudinal association between telomere length and plasma
inflammatory biomarker concentrations including: CRP, SAA, sICAM-1, sVCAM-1, VEGF, TNF-a, IL-1b, IL-2, IL-6, IL-8, and IL-10.
Methods: The longitudinal study population consisted of 87 subjects. The follow-up period was approximately 2 years.
Plasma inflammatory biomarker concentrations were assessed using highly sensitive electrochemiluminescent assays.
Leukocyte relative telomere length was assessed using Real-Time qPCR. Linear mixed effects regression models were used
to analyze the association between repeated-measurements of relative telomere length as the outcome and each
inflammatory biomarker concentration as continuous exposures separately. The analyses controlled for major potential
confounders and white blood cell differentials.
Results: At any follow-up time, each incremental ng/mL increase in plasma CRP concentration was associated with a
decrease in telomere length of 22.661022 (95%CI: 24.361022, 28.261023, p = 0.004) units. Similarly, the estimate for the
negative linear association between SAA and telomere length was 22.661022 (95%CI:24.561022, 26.161023, p = 0.011).
No statistically significant associations were observed between telomere length and plasma concentrations of pro-
inflammatory interleukins, TNF-a, and VEGF.
Conclusions: Findings from this study suggest that increased systemic inflammation, consistent with vascular injury, is
associated with decreased leukocyte telomere length.
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Introduction
Telomeres are nucleoprotein structures which act as vanguards
against chromosomal decay. The repetitive (TTAGGG)n sequenc-
es of telomeres are located at the distal ends of eukaryotic
chromosomes and span 8–12 kb at birth [1]. Erosion of telomeres
below critical lengths may lead to aberrant recombination,
chromosomal fusion, and even subsequent neoplasia. Indeed,
numerous epidemiological investigations have implicated dimin-
ished telomere length with increased risk of adverse health
outcomes. For instance, previous studies have reported that
shorter telomeres were significantly associated with increased
overall cancer risk, in addition to decreased survival rate amongst
diagnosed cases [2–4]. Furthermore, truncated telomeres have
been found to be associated with increased risk of cardiovascular
diseases [5]. Telomeres truncate by 30–200 bp with every mitotic
division as a consequence of intrinsic limitations in lagging-strand
DNA synthesis [6]. As a result, telomere length may provide a
portrait of the mitotic history of a cell. Maintaining sufficient
telomere length involves an interplay between factors which erode
telomeres, and factors which extend them. Extension of telomeres
PLOS ONE | www.plosone.org 1 January 2014 | Volume 9 | Issue 1 | e87348
can be accomplished via activity of the ribonucleoprotein
telomerase. Although constitutively expressed in germ line tissue
and omnipotent stem cells, telomerase is only basally expressed in
most somatic tissue; thus resulting in gradual decay of telomeric
repeats. Aside from cellular division, telomeric shortening can be
further intensified by extrinsic environmental factors which induce
oxidative stress under conditions of inflammation [6,7]. Therefore,
telomere length may also be viewed as a marker that is reflective of
cellular coping; providing resilience against biochemically-induced
genomic trauma.
Inflammation is a complex physiological response to deleterious
stimuli such as injury and infection. The inflammatory process
may be acute as a result of transient stimuli, or may persist as a
chronic state as a result of continual exposure. Chronic
inflammation is an underlying pathophysiological basis of numer-
ous diseases such as cancer, myocardial infarction, and lung failure
[8]. With recurrent injury to tissue, subsequent cell death, scarring,
and fibrosis may lead to permanent loss of function [8].
Chronic inflammation may result in both cellular apoptosis and
necrosis; facilitating the release of potent reactive oxygen species
(ROS) such as superoxides, hydroxyl radicals, and hydrogen
peroxide from mitochondria into the vicinity [9–11]. These
oxidizing agents can induce genomic trauma such as double-
stranded breaks and chemical changes to the telomeric sequences
of DNA. Indeed, previous studies found that exposure to airborne
particulate matter is associated with increased oxidative damage to
the genome, as reflected by urinary concentrations of 8-
hydroxydeoxyguanosine (8-OHdG), an oxidized nucleoside of
DNA [12]. Furthermore, oxidative stress has also been shown to
produce chemical alterations to purines and pyrimidines of
telomeric oligonucleotides in the form of 8-oxoguanine adducts
[13]. Should these chemical alterations occur in vivo, inhibition of
the interaction between Telomeric repeat-binding factors (TRF1/
TRF2) and telomeric sequences may produce instability of the
shelterin loop complex; potentially leading to telomeric erosion,
dysregulation of gene expression, chromosomal fusion, and
disruption of cellular function [14].
Recent studies found that prolonged exposure to particulate air
pollution increases levels of acute phase proteins and vascular
injury related inflammatory mediators including C-Reactive
Protein (CRP), serum intercellular adhesion molecule-1 (sICAM-
1), and serum vascular cell adhesion molecule-1 (sVCAM-1);
important biomarkers of cancer and cardiovascular disease
[15,16]. Additionally, inflammation may trigger the release of
interleukins (IL); a subset of cytokines which can produce highly
variable physiological and immune responses in different cell types
[17]. In particular, Interleukin-1 (IL-1) is a pro-inflammatory
cytokine primarily produced by macrophages, that mediates
inflammatory diseases by initiating and potentiating inflammatory
responses and hematopoiesis [18]. Interleukin-8 (IL-8) is an
equally important cytokine produced by macrophages, which acts
as a chemo-attractant for neutrophils during acute inflammatory
responses. Moreover, IL-8 has been shown induce rapid mobili-
zation of hematopoietic stem cells (HSC) and subsequent
differentiation into leukocytes. This attribute of IL-8 may have
important implications with respect to telomere erosion since
increased mitotic division is required to replenish mobilized HSC
[19]. Although inflammation and immune response may be
responsible for both cytokine production and telomeric erosion, a
number of interleukins including IL-2, IL-4, IL-6, and IL-10 have
been shown to increase telomerase activity in vitro which may
maintain telomere length; illustrating the complexity of these
molecular interactions [14,15].
Despite numerous studies showing the association between
telomere length and various chronic diseases, the intricate causal
relationship between these variables has been difficult to unravel.
The association between telomere length and disease may be
driven by an unmeasured common cause (confounder), such as
underlying chronic inflammation. Although the association
between inflammatory markers and chronic health outcomes such
as cardiovascular disease has been firmly established, the
relationship between these markers and telomere dynamics is less
defined. IL-6, CRP, and Tumor Necrosis Factor (TNF-a) have
been found in several studies to be associated with decreased
telomere length [20] [21] [22]. Although well-powered, most of
these studies have been of cross-sectional design. Investigation into
the biological interplay between these molecular markers over
time in a longitudinal setting would further add to the
understanding of the etiological basis of chronic diseases.
Therefore, the objective of this study was to determine the
longitudinal associations between telomere length and plasma
inflammatory biomarker concentrations including: CRP, Serum
Amyloid A (SAA), sICAM-1, sVCAM-1, Vascular Endothelial
Growth Factor (VEGF), TNF-a, IL-1b, IL-2, IL-6, IL-8, and IL-
10. Furthermore, we explored whether these inflammatory
biomarkers modify the rate of telomeric change over a 2 year
follow-up period. We hypothesize that increased levels of pro-
inflammatory biomarkers is correlated with decreased telomere
length, and intensifies the rate of erosion over the follow-up
period. The prospective determination of plasma inflammatory
mediators and telomere length at multiple time points is
particularly important in addressing numerous gaps in current
knowledge, including the dynamic relationship between inflam-
mation, immune response, and genomic trauma.
Materials and Methods
Study Design
The Harvard Boilermakers Longitudinal Study is a prospective
open-cohort comprised of a series of periodic short-term panel
studies. The source population consists of members of the
International Brotherhood of Boilermakers Union, Local 29 in
Quincy, MA. There are currently 400 active union members, 190
of which have been prospectively followed since 1999. Their
primary occupational activity is welding, assembling, and repair-
ing boilers that provide high-pressure steam to drive electrical
turbines in power plants. Therefore, they are exposed to
environments with high-levels of occupational fine particulate
matter (PM2.5). The follow-up period for the current longitudinal
study was from January 29th 2010 to June 16th 2012. The current
study population consisted of a panel of 87 subjects at baseline.
The inclusion criteria for this study were being male union
members, apprentices or journeymen, and over 18 years of age at
the time of recruitment. The timescale of interest was days of
follow-up, while repeated measures of the outcome and predictors
were obtained at irregularly spaced time intervals between baseline
blood draw and the end of follow-up (Figure 1). A total of 350
inflammatory biomarker measurements and 244 telomere mea-
surements were obtained for the 87 subjects, with an average of 3
measurements per subject. One subject diagnosed with arthritis
and having a history of myocardial infarction was excluded from
the analysis.
Ethics Statement
This observational study was approved the by Institutional
Review Board at the Harvard School of Public Health (OHRA
Protocol #: P10444, Cardiopulmonary Response to Particulate
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Exposure, PI: David C. Christiani). Informed written consent was
obtained from all subjects prior to inclusion in the study.
Exposure Assessment
Vascular Injury Biomarkers and Pro-inflammatory
Cytokines. Whole blood samples were drawn from subjects
by a certified phlebotomist into collection tubes containing EDTA.
Plasma was isolated from whole blood by centrifugation at 1200
RPM for 12 minutes. Plasma samples were then aliquoted into
cryogenic tubes and stored at 280uC. The number of freeze-thaw
cycles prior to the assay was limited to one. Plasma concentrations
of CRP, SAA, sICAM-1, and sVCAM-1 were assessed via
multiplex electrochemiluminescence using the MULTI-SPOTH
96-well Human Vascular Injury Panel II assay (Meso Scale
Discovery, Rockville MD) as per manufacturer’s protocol.
Similarly, plasma concentrations of IL-1b, IL-2, IL-6, IL-8, IL-
10, TNF-a, and VEGF were assessed using the 7-plex MULTI-
ARRAYH 96-well custom cytokine/chemokine assay. Duplicate
reactions were performed on the same 96-well plate, each using
10 mL of plasma. Repeated measurements over time for each
individual subject were performed on the same 96-well plate.
MULTI-SPOTH vascular injury plates contained an 8-point
standard curve from 0–1000 ng/mL with 7-fold dilutions, in
order to derive inflammatory marker concentration. The MULTI-
ARRAYH cytokine plates contained an 8-point standard curve
from 0–2500 pg/mL with 4-fold dilutions. Electrochemilumines-
cent signals from the MULTI-SPOTH and MULTI-ARRAYH
assay plates were read using a SI2400A Sector Imager (Meso Scale
Discovery, Rockville MD). Three quality control samples were
interspersed through-out all assay plates in duplicate. The average
within-plate % coefficients of variation (%CVs) ranged from
7.6%–10.9% for the different assays. The average between-plate
%CVs ranged from 12.3%–17.4% for the different assays.
Outcome Assessment
Telomere Real-Time Quantitative PCR. Buffy coat was
extracted from whole blood and stored in cell lyses solution at 2
20uC until DNA extraction. Peripheral blood leukocyte DNA was
extracted using the QIAmp DNA blood kits (QIAGEN, Venlo,
Netherlands). Average relative telomere length was assessed using
Real-Time Quantitative PCR (qPCR) [23]. This assay determines
the copy-number ratio between telomeric repeats and a single-
copy (36B4) reference gene (T/S Ratio, -dCt). The T/S ratio is
reflective of the average telomere length across all chromosomes in
a population of cells and was calculated for each participant by
subtracting the average 36B4 threshold cycle (Ct) value from the
average telomere Ct value. The T/S ratio value for all
experimental samples was then compared to the T/S ratio of a
reference sample, consisting of a pooled genomic DNA sample.
The relative T/S ratio (-ddCt) was determined by subtracting the
T/S ratio of the reference sample from the T/S ratio of each
unknown sample, and then exponentiating (22ddCt). A modified
version of the qPCR telomere assay was performed in a 384-well
format with a 7900HT PCR System (Life Technologies, Carlsbad,
CA). Briefly, 5 ng of buffy-coat derived genomic DNA was dried
down in a 384-well plate and resuspended in 10 mL of either the
telomere or 36B4 reaction mixture for 2 hours at 4uC. The
telomere reaction mixture consisted of 16 Quantitect SYBR
Green Master Mix (Qiagen, Venlo, Netherlands), 2.5 mM of
DTT, 270 nM of Tel-1 primer-(GGTTTTTGAGGGT-
GAGGGTGAGGGTGAGGGTG AGGGT), and 900 nM of
Tel-2 primer-(TCCCGACTATCCCTATCCCTATCCC-
TATCCCTATCCCTA). The reaction proceeded for 1 cycle at
95uC for 5 min, followed by 40 cycles at 95uC for 15 sec, and
54uC for 2 min. The 36B4 reaction consisted of 16Quantitect
SYBR Green Master Mix, 300 nM of 36B4U primer-(CAG-
CAAGTGGGAAGGTGTAATCC), and 500 nM of 36B4D
primer- (CCCATTCTATCATCAACGGGTACAA). The 36B4
reaction proceeded for 1 cycle at 95uC for 5 min, followed by 40
cycles at 95uC for 15 sec, and 58uC for 1 min 10 sec. All samples
for both the telomere and 36B4 reactions were performed in
triplicate on different plates. Each 384-well plate contained a 6-
point standard curve from 0.625 ng to 20 ng to assess PCR
efficiency. The slope of the standard curve for both the telomere
and 36B4 reactions was 23.40+/20.15. Quality control samples
were interspersed throughout the plates in order to assess inter-
plate and intra-plate variability of Ct values. The inter-plate
%CVs for both the telomere Ct and 36B4 Ct values were under
0.75%. Multiple relative telomere length measurements for each
subject within the same unit of follow-up time (day) were dropped
at random.
White Blood Cell Differentials
Complete blood counts including leukocyte differentials were
assessed using a XE-2100TM Automated Hematology System
(Sysmex, Kobe, Japan) by Laboratory Corporation of America
Holdings (LabCorp) (Newton, MA). Previous studies have
suggested telomere lengths vary between different leukocyte
subtypes [24,25]. Therefore, telomere length assessment may be
affected if the compositional proportion of these subtypes is
altered. This augmentation in proportion may not represent a true
change in the telomere length of a given cell, but rather reflects a
change in the population of cells within a given sample. The
change in proportion could be due to infection or injury during
blood draw, immunologic abnormalities, or inflammatory condi-
tions. Therefore, it was prudent to control for white blood cell
differentials in the analysis.
Covariate Assessment
Self-reported questionnaires were used to collect demographic
data such as birthdate, sex, race, smoking status, current smoking
intensity, and work history. Number of years as a boilermaker was
used as a surrogate variable for long-term particulate matter
exposure from welding fumes [26,27]. Anthropometric data such
as height and weight used to derive body mass index (BMI) were
measured by research personnel at the study site.
Analysis
Linear Mixed Models for Longitudinal Analysis. Linear
mixed effects regression models with random intercept were used
to estimate the association between repeated measures of relative
Figure 1. Repeated-Measures Data Collection of the Harvard
Boilermakers Longitudinal Study.
doi:10.1371/journal.pone.0087348.g001
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telomere length as the outcome, and plasma inflammatory
biomarker concentrations as continuous exposures. Separate
models were used for each inflammatory marker. The models
also controlled for covariates including log-transformed number of
years as a boilermaker at baseline (continuous), time-varying log-
transformed BMI (continuous, log kg/m2), age at baseline blood
draw (continuous), current smoking intensity (cigarettes per day),
and white blood cell differentials including neutrophil %,
lymphocyte %, monocyte %, and eosinophil %. Basophil
proportions were not controlled for because of miniscule
percentages and lack of variability. Interaction terms between
the exposure and follow-up time were included to explore effect
modification of the rate of telomeric change. Analysis was
implemented in SAS v9.3 using PROC MIXED. In order to
obtain unbiased estimates with a limited sample size, restricted
maximum likelihood (REML) was used to estimate the coefficients
and variance-covariance matrices.
Adjustment for Family-Wise Error Rate. Separate linear
mixed effects models were used to estimate the association
between each inflammatory biomarker and telomere length. Each
inflammatory biomarker was classified into one of two families
because of differences of effects in the inflammatory process, vast
disparities in plasma concentration ranges, and assessment on
different assay platforms. The first family consisting of CRP, SAA,
sICAM-1, and sVCAM-1, were vascular injury markers measured
in the ng/mL range using the quadraplex MULTI-SPOTH assay.
The second family consisting of IL-1b, IL-2, IL-6, IL-8, IL-10,
VEGF, and TNF-a, were inflammatory cytokines/chemokines
assessed in the pg/mL range using the 7-plex MULTI-ARRAYH
assay. Therefore, Bonferroni adjusted a-values of 0.013 and 0.007
were used to control family-wise error rate in the vascular injury
family and inflammatory cytokine family respectively. Although
Bonferroni correction was first developed under the assumption of
independence between tests, it can also be used in situations where
the tests maybe dependent as with plasma biomarkers. When
multiple tests are dependent, Bonferroni correction is considered
to be ‘‘conservative’’ in that the true family-wise risk of a type-I
error (false-positive) is less than the stated family-wise a [28,29]. In
other words, when the assumption of independence is violated,
Bonferroni adjustment still protects well against false-positives, but
has less power to detect true effects [28,29].
Management of Missing Data. The study population was
an open cohort with staggered entry and loss of follow-up.
Furthermore, data collection occurred at irregularly spaced time
intervals. Therefore, outcome and predictor data was unbalanced
across the time points. Linear mixed models do not require
outcome data to be balanced nor collected at regularly spaced
intervals because they use maximum likelihood (ML) or REML to
estimate the coefficients and covariance structures; allowing all
available data to be used [30]. The estimates are valid under the
assumption that data are missing at random (MAR) and
distributional assumptions are correct [30]. However, verification
of MAR assumptions is nearly impossible in epidemiological
studies [31]. Inflammatory biomarker readings below the lowest
point of the linear range of the standard curve were assigned half
the value of the minimum detection limit and retained for analysis
[32,33].
Results
Baseline Study Population Characteristics
The study population was composed of 87 male subjects. The
subjects were 86.1% self-identified white, whereas the remaining
subjects were self-identified as African-American, Hispanic, and
Asian (Table 1). One-way ANOVA analysis indicated no statistical
difference in telomere length between self-reported racial groups.
Self-identified race was not controlled for in the analysis because
there was no statistical difference between categories and the
majority of subjects were of white heritage. Current smokers
composed 35.6% and ever-smokers composed 54.0% of the study
population at baseline. A two-sample Student’s t-test indicated no
statistical difference in telomere length between smokers and non-
smokers. Furthermore, there was no statistical difference in
telomere length between ever-smokers and never smokers.
However, current smoking intensity was included as a confounder
in subsequent analysis because of its established causal relationship
with telomere length [34–36]. The average age at baseline was
41.5+/213.0SD years; having worked an average of 11.1+/2
10.4SD years as a boilermaker. The average BMI was 28.4+/2
4.8 kg/m2.
Linear Mixed Models: Longitudinal Analysis of the
Association between Vascular Injury Related
Inflammatory Markers and Telomere Length
After Bonferroni adjustment of a-levels, statistically significant
negative associations were found between telomere length and
plasma concentrations of both CRP and SAA (Table 2). At any
follow-up time, each incremental ng/mL increase in CRP
concentration was associated with a decrease in telomere length
of 22.661022 (95%CI: 24.361022, 28.261023, p = 0.004)
units, while controlling for other covariates. Similarly, the estimate
for the negative linear association between SAA and telomere
length was 22.661022 (95%CI:24.561022, 26.161023,
p = 0.011). None of the interaction terms between follow-up time
and vascular injury inflammatory markers were significant.
Although the main effects for sICAM-1 and sVCAM-1 on
telomere length were not statistically significant after adjustment
for family-wise error rate, they were marginally significant with an
unadjusted a-level of 0.05. As with CRP and SAA, the effect
estimates of 22.461022 (95%CI: 24.861022, 29.061025,
p = 0.049) for sICAM-1 and 22.461022(95%CI: 24.661022,
22.161023, p = 0.032) for sVCAM-1 indicated negative linear
associations with telomere length. The rate of telomeric decay had
an approximate range of 0.0007–0.0015 units per day, at any
concentration of the vascular injury markers and controlling for
predictors.
Linear Mixed Models: Longitudinal Analysis of the
Association between Inflammatory Cytokines/
Chemokines and Telomere Length
After adjustment for family-wise error rate, no statistically
significant associations were found between telomere length and
the panel of inflammatory cytokines/chemokines composed of IL-
1b, IL-2, IL-6, IL-8, IL-10, TNF-a, and VEGF (Table 3).
Furthermore, none of the interaction terms between follow-up
time and inflammatory cytokines/chemokines were significant.
The rate of telomeric attrition had an approximate range of 0–
0.0006 units per day, at any concentration of the inflammatory
cytokines and controlling for predictors.
Discussion
This is one of the few longitudinal studies which examined the
relationship between expression levels of an extensive panel of pro-
inflammatory markers and telomere length dynamics. Further-
more, the prospective study design incorporates a recent
methodological shift in approaching the study of telomeres;
Inflammatory Biomarkers and Telomere Length
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evaluating both telomere length and the rate of change, as
opposed to treating telomeres as static entities in epidemiological
studies. The primary finding of this study was that increased
plasma CRP and SAA concentrations were associated with
decrease leukocyte telomere length. Thus far, no other epidemi-
ological study has examined the association between SAA and
telomere length. However, the results with respect to CRP were in
concordance with findings from previous cross-sectional studies.
The current study focused on an occupational cohort of mostly
healthy, middle-aged, white-American men. In contrast, the
previous Ten Town Heart Health Study of European and South
Asian adolescents ages 13–16 years found that for every unit
increase in CRP concentration, there was a 0.026 (95%CI: 0.011,
0.041, p,0.001) unit decrease in telomere length [22]. In the
Nova Scotia Health Survey of 1995, those in the lowest tertile of
telomere length (4.1–5.0 kb) had significantly higher levels of
serum CRP levels compared to those in the middle (5.0–5.5 kb)
and highest tertile of telomere length (5.5–8.2 kb) p-trend = 0.005
[37]. Furthermore, the Cardiovascular Health Study found a
similar negative association between CRP concentration and
telomere length with an estimate of 20.059+/20.003SE, p = 0.02
[20].
CRP is a non-specific acute phase protein produced in the liver
[38]. CRP is typically undetected in the plasma of healthy
individuals; however, its concentration dramatically rises with
localized and systemic inflammation. Although expressed during
inflammatory response, CRP is not informative with respect to
specific locations of injury [38]. The physiological purpose of CRP
is to bind to phosphocholine expressed on the outer plasma
membrane of apoptotic and necrotic cells to activate the
complement system and subsequent phagocytosis [39]. Further-
more, cells undergoing apoptosis and necrosis experience genomic
degradation mediated by caspase-activated and waste-manage-
ment DNA nucleases, respectively [40]. Apoptotic and necrotic
cells can also release reactive oxygen species from their
mitochondria which can further induce oxidative damage to the
telomeres of neighboring cells. Therefore, the negative correlation
between increased plasma CRP and decreased telomere length
may be attributed to the common cause of inflammation,
mediated through oxidative cell damage. However, the cytotox-
icity of the prominent occupational exposure (particulate matter
Table 1. Characteristics of the Harvard Boilermakers Longitudinal Study Population at Baseline.
Variable Total n =87 Mean Relative
Frequency (%) Telomere Length Std. Dev. p-value `
Current Smoking Status
Non-smoker 52 59.8 0.60 0.18 0.22
Smoker 31 35.6 0.66 0.17
Past Smoking Status
Never 17 19.5 0.63 0.22 0.99
Ever 47 54.0 0.63 0.17
Self-Reported Race
White 71 81.6 0.62 0.17 0.71
African-American 7 8.0 0.61 0.22
Hispanic 3 3.4 0.66 0.28
Asian 2 2.3 0.76 0.11
Mean Std. Dev. Median IQR
Age 41.5 13.0 40.0 31.4–51.5
Number of Years Working as a Boilermaker 11.1 10.5 9.0 3.0–11.5
Body Mass Index (BMI) (kg/m2) 28.4 4.8 27.3 25.2–32.4
Relative Telomere Length (22ddCt) 0.63 0.18 0.60 0.5–0.7
Plasma C-Reactive Protein (CRP) Conc. (ng/mL) 4790 7602 2740 896–6064
Plasma Serum Amyloid A (SAA) Conc. (ng/mL) 5636 2881 8887 1260–6722
Plasma sICAM-1 Conc. (ng/mL) 358 121 346 282–426
Plasma sVCAM-1 Conc. (ng/mL) 531 181 527 406–628
Plasma VEGF Conc. (pg/mL) 380 237 343 148–469
Plasma TNF-a (pg/mL) 12.2 12.4 11.0 8.2–13.2
Plasma Interleukin-1 (IL-1b) Conc. (pg/mL) 1.3 2.5 0.5 0–1.4
Plasma Interleukin-2 (IL-2) Conc. (pg/mL) 4.4 14.4 2.0 1.0–3.4
Plasma Interleukin-6 (IL-6) Conc. (pg/mL) 25.2 20.9 18.3 12.2–28.6
Plasma Interleukin-8 (IL-8) Conc. (pg/mL) 17.7 17.0 14.6 10.0–19.8
Plasma Interleukin-10 (IL-10) Conc. (pg/mL) 7.0 7.0 5.5 4.0–7.6
`A two-sample Student’s T-Test was used to compare telomere length in covariates with two categories (t-statistic), whereas a one-way ANOVA was used to evaluate
covariates with three or more categories (F-statistic). *p-values#0.05 were considered statistically significant.
Discrepancies in counts due to missing data.
doi:10.1371/journal.pone.0087348.t001
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from welding fumes) on the target tissue was not assessed due to
the obvious practical limitations of population-based epidemio-
logical studies. However, PM2.5 has been shown in observational
studies to be associated with increased inflammatory response, in
addition to being shown in laboratory studies to induce cytotoxic
cell death [41] [42] [43].
Serum Amyloid A is also an acute phase protein which is
elevated during acute and systemic inflammation. SAA is primarily
produced by the liver and is associated with high-density
lipoprotein (HDL) in the circulation [44]. However, the exact in
vivo functions of SAA are still not well defined [45].
The association between SAA and telomere length may be
driven the common cause of adiposity.
SAA is also produced by adipocytes and is correlated with
obesity and insulin resistance [46]. Adipose cells also produce
endogenous 17b-estradiols which can act as potent mitogens.
Therefore, increased estradiol-induced mitotic division of HSC
may result in increased telomere erosion in leukocytes [47].
Furthermore, increased adiposity has also been linked with
elevated vascular injury and inflammation, for which SAA is a
marker [48]. Inflammation from adiposity-related vascular injury
may cause apoptotic or necrotic cell death, and subsequent
telomere shortening by the aforementioned mechanisms. BMI is a
convenient measure which is commonly used in epidemiological
studies to control for confounding by adiposity. Although BMI was
controlled in the analysis, it is not a perfect surrogate for degree of
adiposity [49]. The median BMI of the study population was high,
but from a qualitative standpoint, it was not fully representative of
adiposity due to the muscular nature of the boilermaker subjects.
Therefore, there may be residual confounding by adiposity in the
relationship between inflammation and telomere length. However,
the estimate was quite significant even after Bonferroni-adjust-
ment, which would suggest that the degree of residual confounding
would have to be substantial in order to explain the observed
association. Given the direction and magnitude of the observed
association between telomere length, CRP, sICAM-1, and
sVCAM-1; it was more likely that vascular-injury related
inflammation, for which SAA is another marker, explains more
of the variability in telomere length than residual confounding by
adiposity.
In contrast to the vascular injury marker panel, no significant
associations between inflammatory IL, chemokines, and telomere
length were found in this study. Previous studies found significant
relationships between these molecular markers. In particular, the
Health, Aging, and Body Composition Study found that
cumulative inflammatory load, as indexed by the combination of
high levels of IL-6 and TNF-a, was associated with increased odds
for short leukocyte telomeres [21]. Furthermore, a study of renal
cancer found significant positive correlations between tumor TL
and peripheral levels of IL-8 and IL-10 [50]. There may be both
biological and methodological explanations for the discrepancy in
findings between the studies. As previously mentioned, inflamma-
tion may be responsible for both IL production and telomeric
erosion; however, interleukins including IL-2, IL-4, IL-6, and IL-
10 have been shown to increase telomerase activity, thus
maintaining telomere length [51,52]. Since the activity of various
IL is diverse, the biological effects of each IL may counteract each
other. Furthermore, differences in the underlying exposure profiles
and inflammatory conditions between the subjects of various
studies may induce production of different IL and/or differing
amounts of IL. Indeed, the distribution of exposures and
demographic characteristics such as PM2.5 exposure, age, gender,
socioeconomic status, and race were substantially different across
studies. Additionally, there were significant differences in study
Table 2. The Association between Vascular Injury Inflammatory Markers and Telomere Length.
C-Reactive Protein (CRP) Estimate 95%CI Lower 95%CI Upper p-value
Main Effect (log ng/mL) 22.6 x1022 24.3 x1022 28.2 x1023 0.004 *
Follow-up time (days) 26.9 x1024 21.4 x1023 2.6 x1025 0.059
Main Effect x Follow-up time 4.8 x1025 24.0 x1025 1.4 x1024 0.301
Serum Amyloid A (SAA)
Main Effect (log ng/mL) 22.6 x1022 24.5 x1022 26.1 x1023 0.011 *
Follow-up time (days) 28.8 x1024 21.7 x1023 26.0 x1025 0.036
Main Effect x Follow-up time 6.9 x1025 23.0 x1025 1.7 x1024 0.176
Intercellular Adhesion Molecule (sICAM-1)
Main Effect (log ng/mL) 22.4 x1022 24.8 x1022 29.0 x1025 0.049
Follow-up time (days) 21.5 x1023 22.5 x1023 25.6 x1024 0.002 *
Main Effect x Follow-up time 2.1 x1024 4.1 x1025 3.8 x1024 0.015
Vascular Cell Adhesion Molecule (sVCAM-1)
Main Effect (log ng/mL) 22.4 x1022 24.6 x1022 22.1 x1023 0.032
Follow-up time (days) 21.5 x1023 22.4 x1023 25.2 x1024 0.003 *
Main Effect x Follow-up time 1.8 x1024 3.1 x1025 3.3 x1024 0.019
Separate linear mixed models were used for each inflammatory marker. Models controlled for white blood cell count, neutrophil %, lymphocyte %, monocyte %,
eosinophil %, current smoking intensity (cigarettes per day), age at baseline blood draw (years), BMI (log kg/m2), and years as a boilermaker (log years). Main effects
were log-transformed to achieve a normal distribution.*p-values below the Bonferroni-adjusted a-level of 0.013 were considered statistically significant.
The estimate for the main effect represents the difference in telomere length per incremental ng/mL increase in the inflammatory marker at any follow-up time,
controlling for other predictors. The estimate for follow-up time represents the rate of telomeric change; the difference in telomere length per day of follow-up when all
other predictors are at zero. The estimate for the main effect x follow-up time interaction represents effect modification of the rate of telomeric change by the
inflammatory marker; the change in telomere length per ng/mL increase in the inflammatory marker over each day of follow-up time, holding other predictors constant.
95% Confidence Intervals (95%CI) are the bounds in which with more independent samplings, the true estimate will fall within this range in 95% of those samplings.
doi:10.1371/journal.pone.0087348.t002
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design, exposure assessment and operationalization, outcome
assessment, and analysis between studies. In regards to our study,
the variability in plasma IL concentrations may have been too
narrow to drive variability in telomere length. In contrast, the
plasma concentrations of vascular injury markers were much
broader. Although the statistical power of this study was
substantially increased with the use of repeated-measures, the
sample size may not have been sufficient to compensate for the
narrow variability of the plasma IL.
Interestingly, none of the interaction terms between follow-up
time and inflammatory markers examined in this study reached
statistical significance. These null-findings are consistent with the
hypothesis that immune response does not alter the rate of
telomeric decay. However, caution should be taken when
interpreting these findings, because the limited sample size and
follow-up duration of this study precludes definitive evaluation of
effect modification of rates. Although repeated-measures increase
the power to detect subtle effects, there was a possibility that the
null interactions may be non-informative. Furthermore, previous
studies have shown that the rate of telomeric decay is greatest
during early developmental stages of rapid growth between 0–10
years of age; whereas the rate of attrition significantly decreases
into post-adolescence and adulthood [53]. Indeed, only miniscule
rates of attrition were observed over a 2 year period in the current
study of adults. Therefore, incredibly substantial effects would be
required in a short follow-up period to drive a truly significant
interaction term, which would be difficult even in studies with
large sample sizes with long follow-up duration.
The most prominent strength of this study was its prospective
design which allowed for improved assessment of the temporality
between exposure, outcome, and covariates. Longitudinal analysis
using mixed effects models allows for the incorporations of time-
varying exposures, outcomes, and covariates; which permits
exploration of the rates of change. Moreover, the longitudinal
design enhances analytical control of confounding. Additionally,
the study design imparts robustness against recall bias of the
Table 3. The Association between Inflammatory Cytokines-Chemokines and Telomere Length.
Interleukin-1b (IL-1b) Estimate 95%CI Lower 95%CI Upper p-value
Main Effect (log pg/mL) 1.7 x1022 22.4 x1022 5.8 x1022 0.409
Follow-up time (days) 23.3 x1024 24.8 x1024 21.8 x1024 ,0.0001 *
Main Effect x Follow-up time 1.1 x1025 21.7 x1024 1.9 x1024 0.903
Interleukin-2 (IL-2)
Main Effect (log pg/mL) 21.3 x1023 23.9 x1022 3.7 x1022 0.948
Follow-up time (days) 23.1 x1024 25.1 x1024 21.0 x1024 0.003 *
Main Effect x Follow-up time 24.0 x1025 22.3 x1024 1.5 x1024 0.661
Interleukin-6 (IL-6)
Main Effect (log pg/mL) 3.8 x1022 28.8 x1023 8.4 x1022 0.110
Follow-up time (days) 1.5 x1025 25.9 x1024 6.2 x1024 0.959
Main Effect x Follow-up time 21.2 x1024 23.1 x1024 7.2 x1025 0.219
Interleukin-8 (IL-8)
Main Effect (log pg/mL) 2.0 x1022 22.6 x1022 6.5 x1022 0.397
Follow-up time (days) 1.0 x1025 24.8 x1024 5.0 x1024 0.968
Main Effect x Follow-up time 21.3 x1024 23.1 x1024 4.6 x1025 0.146
Interleukin-10 (IL-10)
Main Effect (log pg/mL) 22.5 x1022 26.9 x1022 2.0 x1022 0.269
Follow-up time (days) 26.0 x1024 29.7 x1024 22.2 x1024 0.002 *
Main Effect x Follow-up time 1.3 x1024 24.0 x1025 2.9 x1024 0.133
Vascular Endo. Growth Factor (VEGF)
Main Effect (log pg/mL) 1.4 x1022 21.8 x1022 4.7 x1022 0.383
Follow-up time (days) 22.5 x1024 21.1 x1023 6.4 x1024 0.581
Main Effect x Follow-up time 22.0 x1025 21.7 x1024 1.4 x1024 0.836
Tumor Necrosis Factor (TNF-a)
Main Effect (log pg/mL) 2.7 x1023 24.5 x1022 5.1 x1022 0.911
Follow-up time (days) 23.1 x1024 28.6 x1024 2.4 x1024 0.261
Main Effect x Follow-up time 21.0 x1025 22.3 x1024 2.1 x1024 0.927
Separate linear mixed models were used for each cytokine/chemokine. Models controlled for white blood cell count, neutrophil %, lymphocyte %, monocyte %,
eosinophil %, current smoking intensity (cigarettes per day), age at baseline blood draw (years), BMI (log kg/m2), and years as a boilermaker (log years). Main effects
were log-transformed to achieve a normal distribution. *p-values below the Bonferroni-corrected a-level of 0.007 were considered statistically significant.
The estimate for the main effect represents the difference in telomere length per incremental pg/mL increase in the cytokine/chemokine at any follow-up time,
controlling for other predictors. The estimate for follow-up time represents the rate of telomeric change; the difference in telomere length per day of follow-up when all
other predictors are at zero. The estimate for the main effect x follow-up time interaction represents effect modification of the rate of telomeric change by the cytokine/
chemokine; the change in telomere length per pg/mL increase in the cytokine/chemokine over each day of follow-up time, holding other predictors constant. 95%
Confidence Intervals (95%CI) are the bounds in which with more independent samplings, the true estimate will fall within this range in 95% of those samplings.
doi:10.1371/journal.pone.0087348.t003
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exposure and differential misclassification; as both the exposure
and outcome were independent laboratory measurements. More-
over, the use of multiple repeated-measures throughout the follow-
up period substantially increased the statistical power to detect
subtle effects, beyond the apparent sample size of the study.
Notably, exposure assessment was accomplished using highly
sensitive electro-chemiluminescent assays on an extensive panel of
eleven inflammatory markers. The Meso Scale Discovery platform
offers superior dynamic detection ranges, accuracy, and repro-
ducibility compared to traditional ELISA, which allows for more
nuanced analyses of the relationship between inflammatory
biomarkers and telomere length [54]. Furthermore, the outcome
was assessed using qPCR which is currently the most labor- and
cost-effective methods to measure telomere length in epidemio-
logical studies. Not only does qPCR correlate well with gold-
standard Southern blots, but also requires only a fraction of the
genomic DNA, and is robust against detection of centromeric
sequences [23].
As with all scientific investigations, there were limitations of
note. The practical restrictions of occupational epidemiology
studies involving real human subjects creates complexities in the
study design and analysis, which requires nuanced appreciation to
evaluate. For instance, union policies and seasonal work-training
schedules of the boilermaker subjects created a situation in which
entry and exit from the study was staggered, therefore data was
unbalanced. Fortunately, analysis of longitudinal data using
versatile linear mixed models does not require balanced data
under the aforementioned assumptions. There may be the
possibility of bias due to unmeasured confounders. However,
most notable confounders related to inflammatory markers and
telomere length from prior studies were controlled for in the
analysis. Although controlling for time-varying confounders in
traditional models may result in selection bias, the degree of bias
would depend on the true state-of-affairs between all the related
variables; which is inherently unknowable [55]. As with most
occupational cohorts, the sample size of this study was limited.
However, the entire source population from which the subjects
were recruited was only 400 union members; therefore our current
study population contains a significant proportion of the entirety.
The use of multiple repeated-measures should compensate for this
limitation by significantly increasing the statistical power to detect
small effect sizes. There was also the possibility of healthy worker
bias (selection bias) in which healthier subjects with lower
inflammation, and longer telomeres tended to be recruited and/
or remain in the study compared to others. Healthy worker
recruitment bias would reduce generalizability of the results to the
source population. Healthy worker selection bias, a form of loss of
follow-up, would likely bias the estimates towards the null and
underestimate the true effect. Lastly, the linear mixed models may
have been over-adjusted because numerous covariates and white
blood cell differentials needed to be controlled in order to
minimize bias in the estimates. Although the variance may have
been inflated from over-fitting, statistically significant estimates
were still obtained for the analysis involving vascular injury
markers and telomere length.
In summary, this study provides an enticing glimpse into the
relationship between systemic inflammation, immune response,
and genomic degeneration. Significant negative correlations were
found between telomere length and plasma concentrations of CRP
and SAA. Furthermore, marginal yet insignificant negative
associations were found between telomere length, and sICAM-1
and sVCAM-1. Conversely, no significant associations were found
between plasma IL concentrations and telomere length. However,
the limited concentration range of some of the IL in this study does
not preclude their biological effects on telomere dynamics. Taken
together, the findings from this study suggest that increased
systemic inflammation, consistent with vascular injury, is associ-
ated with decreased leukocyte telomere length. Future prospective
studies would benefit from larger sample sizes with a balanced
study design in order to discern subtle effects. Additionally,
extended follow-up periods with equally spaced repeated measures
would be beneficial in accurately assessing effect modification by
inflammatory status on the rate of telomere attrition.
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